DeepCure is meeting with potential investors and partners at #jpm2024. We're excited to share the latest updates on our small molecule pipeline and platform! #inflammation #immunology
Kicked off #jpm2024 for DeepCure with a thought-provoking discussion on AI and drug discovery! A huge thank you to the other panelists (Michelle Chen at Insilico Medicine, Jeff He at TandemAI and Shengfang Jin at Ensem Therapeutics), our moderator (Lan Kang at CBC Group), and The BayHelix Group for organizing the event! Photo source (modified): The BayHelix Group
